Table 1.
Demographic characteristics and symptoms of the 1,788 patients with COVID-19.
| Covariates | All patients, n (%) | ALT | AST | ||||
|---|---|---|---|---|---|---|---|
| Normal, n (%) | Elevated, n (%) | P-value | Normal, n (%) | Elevated, n (%) | P-value | ||
| Gender | <0.001 | 0.056 | |||||
| Female | 913 (52.50) | 833 (91.24) | 80 (8.76) | 848 (92.88) | 65 (7.12) | ||
| Male | 826 (47.50) | 657 (79.54) | 169 (20.46) | 749 (90.68) | 77 (9.32) | ||
| Age, median (IQR) | 59 (49-68) | 60 (49-69) | 54 (43-62) | <0.001 | 59 (49-68) | 59 (47-69) | <0.001 |
| Any comorbidity | |||||||
| Cardiovascular disease | 356 (19.91) | 317 (89.04) | 39 (10.96) | 0.040 | 320 (89.89) | 36 (10.11) | 0.241 |
| Pulmonary disease | 89 (5.12) | 79 (88.76) | 10 (11.24) | 0.394 | 82 (92.13) | 7 (7.87) | 0.915 |
| Endocrine disease | 137 (7.66) | 124 (90.51) | 13 (9.49) | 0.090 | 132 (96.35) | 5 (3.65) | 0.033 |
| Malignancy | 64 (3.58) | 54 (84.38) | 10 (15.63) | 0.771 | 56 (87.50) | 8 (12.50) | 0.251 |
| Digest system disease | 45 (2.52) | 37 (82.22) | 8 (17.78) | 0.510 | 36 (80.00) | 9 (20.00) | 0.005 |
| Neurological disease | 56 (3.13) | 51 (91.07) | 5 (8.93) | 0.238 | 49 (87.50) | 7 (12.50) | 0.284 |
| Initial symptoms | |||||||
| Fever or fatigue | 620 (34.68) | 516 (83.23) | 104 (16.77) | 0.035 | 547 (88.23) | 73 (11.77) | <0.001 |
| Respiratory symptoms | 635 (35.51) | 543 (85.51) | 92 (14.49) | 0.918 | 568 (89.45) | 67 (10.55) | 0.025 |
| Digestive symptoms | 82 (4.59) | 70 (85.37) | 12 (14.63) | 0.945 | 72 (87.80) | 10 (12.20) | 0.228 |
| Neurological symptoms | 26 (1.45) | 21 (80.77) | 5 (19.23) | 0.315 | 23 (88.46) | 3 (11.54) | 0.483 |
| Other | 23 (1.45) | 23 (88.46) | 3 (11.54) | 0.474 | 26 (100) | 0 (0) | 0.161 |